Neuropathic pain (NP) is a disabling condition that may occur following a disease or a lesion of the somatosensory nervous system. With an estimated prevalence of up to 8.2% in the general population, NP is common, and robust and objective diagnostic tools are warranted for pain assessment and follow-up. In the last years research has focused on defining biochemical and histological markers for this purpose, and possible systemic (blood, cerebrospinal fluid) and local (skin and nerve) targets have been investigated in a number of different NP disorders. This article focuses on an update giving an overview over some potential biomarkers for the diagnosis of NP, and will discuss their clinical relevance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据